Cambridge Investment Research Advisors »

Plus Therapeutics shares owned by Cambridge Investment Research Advisors

Quarter-by-quarter ownership of Plus Therapeutics (PSTV) shares owned by Cambridge Investment Research Advisors from 13F filings

Historical chart of Cambridge Investment Research Advisors investment in Plus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Plus Therapeutics held by Cambridge Investment Research Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Plus Therapeutics by Cambridge Investment Research Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $7.0k 11k 0.67

More positions owned by Cambridge Investment Research Advisors

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Apple Inc Com (AAPL)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard Index Fds Total Stk Mkt (VTI)
Ishares Tr Core S&p500 Etf (IVV)
Microsoft Corp Com (MSFT)
Amazon Com Inc Com (AMZN)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
SPDR S&p 500 Etf Tr Tr Unit (SPY)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Capital Group Dividend Value Shs Creation Uni (CGDV)
Meta Platforms Inc Cl A (META)
Vanguard Index Fds Growth Etf (VUG)
Spdr Series Trust Portfolio S&P500 (SPLG)

View all positions for Cambridge Investment Research Advisors

Top funds holding Plus Therapeutics

Vanguard Group
Altium Capital Management
Geode Capital Management
UBS Group
BlackRock
State Street Corporation
Northern Trust
Scientech Research
Susquehanna International
Mercer Global Advisors
Dagco
Kestra Advisory Services
Cubist Systematic Strategies
Two Sigma Securities
Cambridge Investment Research Advisors

View all funds holding Plus Therapeutics